Novozymes partners Monsanto to develop cotton seed
13/12/2013
The project will look at using bacteria and fungi to optimise the performance of crops, with cotton among a group that has been given priority.
Biologicals are used to complement or replace agricultural chemical products and represent a growing market segment of $2.3 billion in annual sales, according to Monsanto.
Monsanto will make an upfront payment of $300 million and establish the BioAg Alliance, which joins Novozymes' microbial work with Monsanto's commercial capabilities, the companies said.
Share this story:
